In recognition of International Clinical Trials Day, we’re highlighting recent advances in bronchiectasis research made possible through clinical trials.
This short video offers a recap of key randomised controlled trials, including:
GREAT-2
AIRLEAF
ASPEN
Clinical trials are the foundation of progress in bronchiectasis care – helping us better understand the disease, evaluate new treatments, and improve outcomes for people living with it.
At EMBARC, we are proud to support collaborative, international research – but none of it would be possible without the generous participation of patients.
To everyone who takes part in research: thank you.